Compex Technologies Expands Licensing Agreement With BMR; Secures Distribution Rights for Slendertone Products in Key European Markets.

Business Editors/Health/Medical Writers

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--April 22, 2003

Compex Technologies, Inc. (Nasdaq:CMPX) today announced that it has acquired distribution rights for most of Europe to the Slendertone FLEX and GymBody Abs Belts, as well as other products, from Bio Medical Research Ltd. (BMR), a company formed under the laws of Ireland.

"This announcement expands upon our existing agreement with BMR," commented Dan W. Gladney, President and CEO, "and allows both companies to leverage each other's key strengths. For our part, we are able to immediately offer these products at the 4,000 sporting goods outlets through which we currently sell our Compex products. Such immediate distribution capabilities will allow us to expand our electrotherapy retail business."

Mr. Gladney continued, "These new products give us the opportunity to offer a line of entry-level products to complement our high-end products, allowing us to become a single-source vendor. We are able to introduce these new products and leverage our existing salesforce with minimal additional resources. These products will effectively keep consumers focused on our brands and allow us to strengthen our markets, which have seen increased competition recently from competitors offering entry-level products in the marketplace."

"The addition of these products furthers our expansion into the larger fitness and wellness market, in addition to the athletic and sports training markets that we currently operate in" concluded Mr. Gladney. "We continue to search for additional business development and strategic opportunities, particularly those which can increase our sales revenues and cash flow."

Compex Technologies, Inc. is a leading designer, manufacturer and provider of electromedical products used for pain management, rehabilitation and sports training in clinical, home health care, sports and occupational medicine settings.

Cautionary Statement: All statements other than historical facts included in this release regarding future operations, and particularly on the outlook for 2003, are subject to the risks inherent in predictions and "forward looking statements." These statements are based on the beliefs and assumptions of management of Compex Technologies and on information currently available to management. Nevertheless, these forward-looking statements should not be construed as guarantees of future performance. They involve risks, uncertainties, and assumptions identified in Compex Technologies filings with the SEC, including:

-- The increasing reliance on results of international

operations;

-- The effect of fluctuating exchange rates on international

results;

-- Compex Technologies substantial balances of third-party

billing business and resulting accounts receivable and the

sensitivity of its results to the accuracy of its reserve for

uncollectible receivables;

-- Changes in, and Compex Technologies compliance with,

regulation and industry practice that affects the rates at

which its products are reimbursed, the way it manufactures its

products, and the documentation which it submits for

reimbursement.

Other factors that affect the industry in which Compex Technologies functions, including negative publicity about electro-medical stimulation products for medical and fitness applications, and world events that affect the economies of the countries in which its products are sold.